n.adeyemi
Submits third-party assay reports on material purchased directly. Based in Basel.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
10
n=10
Annotations
0
n=0
Median purity submitted
99.03%
n=10
Suppliers covered
10
n=10
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043132 | BPC-157 | SSA | SSA-2601-N6863 | Janoshik | 2026-Q2 | 98.03 | 4.34 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-043072 | Exenatide | KP | KP-2511-W5891 | Kestrel | 2026-Q1 | 98.18 | 3.00 | 94.1 | Buyer-sourced | 0 | PASS |
| AX-2026-042949 | Semaglutide | MKM | MKM-2510-S3812 | VendorInvestigate | 2026-Q1 | 98.66 | 6.11 | 92.2 | Buyer-sourced | 0 | PASS |
| AX-2025-019248 | CJC-1295 (no DAC) | AMB | AMB-2507-S5238 | Nordanalyt | 2025-Q3 | 99.61 | 5.78 | 105.9 | Buyer-sourced | 0 | PASS |
| AX-2025-019971 | Selank | HJ | HJ-2507-F7054 | VendorInvestigate | 2025-Q3 | 99.15 | 8.26 | — | Buyer-sourced | 0 | PASS |
| AX-2025-019634 | BPC-157 | TFC | TFC-2507-J2316 | Medutest | 2025-Q3 | 98.91 | 4.27 | 90.2 | Buyer-sourced | 2 | FAIL |
| AX-2025-018967 | BPC-157 | ASY | ASY-{CAT}-1276 | PeptideMeter | 2025-Q3 | 99.25 | 6.21 | 107.2 | Buyer-sourced | 0 | PASS |
| AX-2024-005276 | Tirzepatide | BCH | BCH-2407-F4650 | PeptideMeter | 2024-Q4 | 97.17 | 5.02 | 107.1 | Supplier-supplied | 2 | MARGINAL |
| AX-2024-004307 | MOTS-c | QSC | QSC-2402-U7154 | Janoshik | 2024-Q3 | 99.93 | 3.09 | — | Buyer-sourced | 0 | PASS |
| AX-2024-004367 | Sermorelin | FGP | FGP-2406-D8645 | Janoshik | 2024-Q3 | 99.37 | 3.47 | 103.2 | Buyer-sourced | 1 | MARGINAL |